Middletown, DE -- (SBWIRE) -- 09/04/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Hologic, Inc.(NASDAQ:HOLX), ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS), Mattel, Inc.(NASDAQ:MAT), Onyx Pharmaceuticals, Inc.(NASDAQ:ONXX)
Hologic, Inc. (NASDAQ:HOLX) gained volume of 2.73 million shares and the average volume of the stock remained 2.87 million shares. The 52 week range of the stock remained $18.45 - $23.96 and the day range was $21.15 - $21.70.The stock opened the session at $21.53, remained amid the day range of $21.15 - $21.70, and closed the session at $21.20. The stock showed a negative performance of -0.66% in previous trading session. Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. The company?s Breast Health segment offers full field digital mammography, C-View, screen-film mammography, computer aided detection.
Has HOLX Found The Bottom and Ready To Move Up? Find Out Here
In previous session, ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) traded 2.70 million shares and the average volume of the stock remained 1.22 million shares. The 52 week range of the stock remained $7.55 - $34.31. The stock was a bull and advanced +3.76%, while its closing price stayed at $26.80. The market capitalization of the stock remained 3.09 billion. The half-yearly trend of the stock remained positive +75.05%. Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company?s flagship product, KYNAMRO injection, is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia for the reduction of low-density lipoprotein cholesterol.
For How Long ISIS will fight for Profitability? Read This Trend Analysis report
Mattel, Inc.(NASDAQ:MAT) volume of the stock was 2.62 million shares in the most recent session and the average volume remained 2.32 million shares. The stock boosted +0.79% and finished the prior session at the closing price of $40.82. The stock traded 2.62 million shares in its previous trading session and its average volume remained 2.32 million shares. Mattel, Inc., together with its subsidiaries, designs, manufactures, and markets various toy products. The company operates in three segments: North America, International, and American Girl. Its products comprise fashion dolls and accessories, vehicles and play sets, and games and puzzles.
Will MAT Continue To Move Higher? Find Out Here
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) traded with volume of 2.60 million shares and the average volume of the stock remained 3.47 million shares. The stock grew +0.13% and finished the trading at $123.74. The market capitalization of the stock remained 9.07 billion. The beta of the stock remained 1.33. Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally.
Why Should Investors Buy ONXX After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)